Skip to content

Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients

Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01785641
Enrollment
300
Registered
2013-02-07
Start date
2012-12-31
Completion date
2013-12-31
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritonitis

Keywords

peritoneal dialysis, peritonitis

Brief summary

To compare the efficacy of single versus combined antibiotic therapy for bacterial peritonitis in CAPD patients.

Detailed description

To compare relapse and recurrent rate of peritonitis between single and combined antibiotic regimens for bacterial peritonitis in CAPD patients.

Interventions

DRUGceftazidime+ciprofloxacin

2 synergistic antibiotics: ceftazidime IP + ciprofloxacin po for gram negative bacterial peritonitis

DRUGceftazidime monotherapy

ceftazidime IP for gram negative bacterial peritonitis

DRUGcefazolin+gentamicin

cefazolin IP + gentamicin IP for gram positive bacterial peritonitis

DRUGcefazolin monotherapy

cefazolin IP for gram positive bacterial peritonitis

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
15 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age \>/= 18 years old * ESRD patients on continuous ambulatory peritoneal dialysis more than 4 weeks * presence of symptom or sign of peritonitis * presence of WBC \>100cell/mm3 with PMN \>50% in peritoneal dialysate or gram stain positive for gram positive or gram negative bacteria

Exclusion criteria

* presence of polymicrobial organism, non-fermentative gram negative organism, fungus, mycobacteria in peritoneal fluid or culture-negative * peritonitis from the organisms that required combined antibiotic therapy according to ISPD guideline 2010 * hospital-acquired peritonitis * presence of catheter-related infection * history of peritonitis within 4 weeks * currently taking antibiotic * allergic to the antibiotic that used in the study(penicillin or cephalosporin or quinolone or aminoglycoside)

Design outcomes

Primary

MeasureTime frame
relapse or recurrent ratewithin 4 weeks after peritonitis treatment

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026